The RAGE Axis A Fundamental Mechanism Signaling Danger to the Vulnerable Vasculature

被引:319
作者
Yan, Shi Fang [1 ]
Ramasamy, Ravichandran [1 ]
Schmidt, Ann Marie [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Surg, Div Surg Sci, New York, NY 10032 USA
关键词
diabetes; cardiovascular complications; RAGE; inflammation; GLYCATION END-PRODUCTS; ENDOTHELIAL PROGENITOR CELLS; CORONARY-ARTERY-DISEASE; EARLY GROWTH RESPONSE-1; MOBILITY GROUP BOX-1; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; SOLUBLE RECEPTOR; UP-REGULATION; ATHEROSCLEROTIC PLAQUES;
D O I
10.1161/CIRCRESAHA.109.212217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The immunoglobulin superfamily molecule RAGE (receptor for advanced glycation end product) transduces the effects of multiple ligands, including AGEs (advanced glycation end products), advanced oxidation protein products, S100/calgranulins, high-mobility group box-1, amyloid-beta peptide, and beta-sheet fibrils. In diabetes, hyperglycemia likely stimulates the initial burst of production of ligands that interact with RAGE and activate signaling mechanisms. Consequently, increased generation of proinflammatory and prothrombotic molecules and reactive oxygen species trigger further cycles of oxidative stress via RAGE, thus setting the stage for augmented damage to diabetic tissues in the face of further insults. Many of the ligand families of RAGE have been identified in atherosclerotic plaques and in the infarcted heart. Together with increased expression of RAGE in diabetic settings, we propose that release and accumulation of RAGE ligands contribute to exaggerated cellular damage. Stopping the vicious cycle of AGE-RAGE and RAGE axis signaling in the vulnerable heart and great vessels may be essential in controlling and preventing the consequences of diabetes. (Circ Res. 2010; 106: 842-853.)
引用
收藏
页码:842 / 853
页数:12
相关论文
共 98 条
[61]   Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo [J].
Moser, Bernhard ;
Desai, Dharmesh D. ;
Downie, Matthew P. ;
Chen, Yali ;
Yan, Shi Fang ;
Herold, Kevan ;
Schmidt, Ann Marie ;
Clynes, Raphael .
JOURNAL OF IMMUNOLOGY, 2007, 179 (12) :8051-8058
[62]   The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage [J].
Muhammad, Sajjad ;
Barakat, Waleed ;
Stoyanov, Stoyan ;
Murikinati, Sasidhar ;
Yang, Huan ;
Tracey, Kevin J. ;
Bendszus, Martin ;
Rossetti, Grazisa ;
Nawroth, Peter P. ;
Bierhaus, Angelika ;
Schwaninger, Markus .
JOURNAL OF NEUROSCIENCE, 2008, 28 (46) :12023-12031
[63]   RAGE control of diabetic nephropathy in a mouse model -: Effects of RAGE gene disruption and administration of low-molecular weight heparin [J].
Myint, Khin-Mar ;
Yamamoto, Yasuhiko ;
Doi, Toshio ;
Kato, Ichiro ;
Harashima, Ai ;
Yonekura, Hideto ;
Watanabe, Takuo ;
Shinohara, Harumichi ;
Takeuchi, Masayoshi ;
Tsuneyama, Koichi ;
Hashimoto, Noriyoshi ;
Asano, Masahide ;
Takasawa, Shin ;
Okamoto, Hiroshi ;
Yamamoto, Hiroshi .
DIABETES, 2006, 55 (09) :2510-2522
[64]   Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes [J].
Nathan, DM ;
Cleary, PA ;
Backlund, JYC ;
Genuth, SM ;
Lachin, JM ;
Orchard, TJ ;
Raskin, P ;
Zinman, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) :2643-2653
[65]   Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation [J].
Palumbo, R ;
Sampaolesi, M ;
De Marchis, F ;
Tonlorenzi, R ;
Colombetti, S ;
Mondino, A ;
Cossu, G ;
Bianchi, ME .
JOURNAL OF CELL BIOLOGY, 2004, 164 (03) :441-449
[66]   Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts [J].
Park', L ;
Raman, KG ;
Lee, KJ ;
Lu, Y ;
Ferran, LJ ;
Chow, WS ;
Stern, D ;
Schmidt, AM .
NATURE MEDICINE, 1998, 4 (09) :1025-1031
[67]  
PARKKINEN J, 1993, J BIOL CHEM, V268, P19726
[68]   The functional-374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients [J].
Pettersson-Fernholm, K ;
Forsblom, C ;
Hudson, BI ;
Perola, M ;
Grant, PJ ;
Groop, PH .
DIABETES, 2003, 52 (03) :891-894
[69]   RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts [J].
Ramasamy, Ravichandran ;
Yan, Shi Fang ;
Schmidt, Ann Marie .
JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 86 (03) :505-512
[70]   A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10) [J].
Raucci, Angela ;
Cugusi, Simona ;
Antonelli, Antonella ;
Barabino, Silvia M. ;
Monti, Lucilla ;
Bierhaus, Angelika ;
Reiss, Karina ;
Saftig, Paul ;
Bianchi, Marco E. .
FASEB JOURNAL, 2008, 22 (10) :3716-3727